Diya Women Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 24-10-2024
- Paid Up Capital ₹ 0.10 M
as on 24-10-2024
- Company Age 5 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue -64.08%
(FY 2023)
- Profit 55.44%
(FY 2023)
- Ebitda 55.91%
(FY 2023)
- Net Worth -29.03%
(FY 2023)
- Total Assets -35.22%
(FY 2023)
About Diya Women
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Veluswamy Aravindchander and Ravichandran Reshmashri serve as directors at the Company.
- CIN/LLPIN
U85100TZ2019PTC033126
- Company No.
033126
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2019
- Date of AGM
12 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Diya Women Private Limited offer?
Diya Women Private Limited offers a wide range of products and services, including Face Mask & Medical PPE Kits, Disposable Shoe Cover, Medical Caps, Towels, Napkins & Handkerchieves, Aprons.
Who are the key members and board of directors at Diya Women?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veluswamy Aravindchander  | Director | 11-Dec-2019 | Current |
| Ravichandran Reshmashri | Director | 11-Dec-2019 | Current |
Financial Performance of Diya Women.
Diya Women Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 64.08% decrease. The company also saw a substantial improvement in profitability, with a 55.44% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diya Women?
In 2023, Diya Women had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr A5 Pharma Private LimitedActive 1 month 4 daysVeluswamy Aravindchander and Ravichandran Reshmashri are mutual person
- Dr. Aravind's Ivf Private LimitedActive 2 years 1 month
Veluswamy Aravindchander and Ravichandran Reshmashri are mutual person
- Ifc Ivf Private LimitedActive 5 years 17 days
Veluswamy Aravindchander and Ravichandran Reshmashri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diya Women?
Unlock and access historical data on people associated with Diya Women, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diya Women, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diya Women's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
